Skip to content

Prophylactic effect of oral Tranexamic Acid on bleeding in knee replacement surgery

Prophylactic effect of oral Tranexamic Acid on bleeding in knee replacement surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190220042773N1
Enrollment
30
Registered
2019-04-09
Start date
2019-03-16
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Joint knee replacement hemorrhage.

Interventions

Intervention 1: The intervention group: consisted of 15 patients who took oral capsules of 250 mg Tranexamic Acid every 6 hours They used a total of 2 g 2 day before knee replacement surgery. Interven

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patient's full conditions for participation in the study and signature of the prepared form of the informed consent A person with a history of specific disease, such as kidney disease, liver disease, history of ischemia, heart, hypertension, history of self-sacrifice and signs of disability in the diagnosis and treatment of disability. Patients do not use aspirin or any other anticoagulants from the week before surgery: Plavix, heparin, enoxaparin, and warfarin. Do not observe a specific diet (it's not just herbivorous or meat-eaters, or the use of certain substances that lower blood glucose levels) Do not use special medication such as iron or other medications associated with bleeding.

Exclusion criteria

Exclusion criteria: Patient dissatisfaction to continue participation Patients with abnormal clotting parameters (PT, PTT, BT, INR, platelet) People with high systolic blood pressure (185 in surgery day) During surgery and up to 6 hours after the operation, the osmotic arterial pressure is more than 20%. Patients with complications such as nausea and vomiting, color blindness, headache and dizziness, thromboemboli, myocardial ischemia and nutritional ischemia before and after surgery.

Design outcomes

Primary

MeasureTime frame
Volume of bleeding in knee replacement surgery. Timepoint: During surgery and 6 hours after surgery and 12 hours after knee replacement. Method of measurement: Level of hemoglobin and platelets, PT, PTT, BT before and after the operation, the amount of blood lost through surgical suction bottles, weighing the used gauzes during surgery and blood on the field of postoperative surgery patients.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Yousef Kolookhi

Islamic Azad University

dryousefkolookhianestezi@gmail.com+98 23 3239 0077

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026